期刊文献+

糖尿病肾病患者血清血管内皮生长因子和色素上皮衍生因子水平变化 被引量:4

Change and Significance of Serum Vascular Endothelial Growth Factor and Pigment Epithelium-derived Factor in Type 2 Diabetic Nephropathy
下载PDF
导出
摘要 目的:探讨2型糖尿病肾病(DN)患者血清血管内皮生长因子(VEGF)和色素上皮衍生因子(PEDF)水平变化及其在DN发生发展中的意义。方法:将175例研究对象分为正常对照组(NC组,n=35)、单纯糖尿病组(T2DM组,n=35)、DNⅢ期组(Ⅲ组,n=40)、DNⅣ期组(Ⅳ组,n=35)、DNⅤ期组(Ⅴ组,n=30)。采用酶联免疫法检测各组血清VEGF及PEDF水平并分析二者相关性,同时测定全血糖化血红蛋白(HbA1c)、血浆纤维蛋白原(Fib)、血肌酐(Cr)及24h尿微量白蛋白排泄率(UAER),并行UAER危险因素的多元回归分析。结果:五组血清PEDF、VEGF水平差异有统计学意义(P<0.01),各病例组水平均高于NC组,且Ⅴ组>Ⅳ组>Ⅲ组,差异均有统计学意义(P<0.01),T2DM组与Ⅲ组比较差异无统计学意义(P>0.05)。研究对象血清VEGF与PEDF水平呈直线相关(r=0.847,P<0.01)。血清VEGF、HbA1c是UAER的独立危险因素(R2=0.430)。结论:VEGF和PEDF可能参与了DN的发生发展。 Objective: To investigate the change of vascular endothelial growth factor (VEGF) and pigment epithelium-derived factor (PEDF) in the development of diabetic nephropathy. Method: 175 subjects were divided into control group(n = 35), T2DM group (n: 35 ), DN III stage group ( III group, n = 40), IV stage group ( IV group, n = 35) and stage group( V group,n= 30). ELISA was used to detect the serum VEGF and PEDF. Blood lipid, fasting plasma glucose,insulin, HBAlc, blood creatinine and fibrinogen were simultaneously determined. Results: The serum level of PEDF, VEGF and Fib increased gradually in the five groups and there were significant difference. Except T2DM group with III group, there were significant difference between other groups. VEGF and PEDF showed linear correlation(r=0. 847 ,P〈0.01). VEGF, HbAlc were significant independent determinants of UAER(R^2= 0. 430). Conclusion: VEGF and PEDF may involve in the development of diabetic nephropathy.
出处 《微循环学杂志》 2015年第3期30-33,共4页 Chinese Journal of Microcirculation
关键词 糖尿病肾病 血管内皮生长因子 色素上皮衍生因子 Diabetic nephropathy Vascular endothelial growth factor Pigment epithelium-derived factor
  • 相关文献

参考文献15

  • 1Itakura H,Akiyama H, Hagimura N,et al. Triamcinolone ace- tonide suppresses intierleukin-1 beta-mediated increase in vascu- lar endothelial growth factor expression in cultured rat Muller cells[J]. Grafe's Arch Clin Exp Ophthalmol,2006,244(2) :226- 231.
  • 2Zhu XF, Zou HD. PEDF in diabetic retinopathy: a protective effect of oxidative stress[J]. J Biomed Biotechnol, 2012,58(8) : 580687.
  • 3Amano S, Yamagishi S, Inagaki Y,et al. Pigment epithelium- de- rived factor inhibits oxidative stress-induced apoptosis and dys- function of cultured retinal pericytes[J]. Microvasc Res, 2005: 45-55.
  • 4Matsuoka M,Ogata N, Minamino K, et al. Expression of pigment epithelium- derived factor angvascular endothelial growth factor in fibrovascular membranes frompatients with proliferative dia- betic retinopathy[J]. J pn J Ophthalmol, 2006,50(2): 116 - 120.
  • 5Wang JJ,Zhang SX,Lu K,et al. Decreased expression of pigment epithelium derived factor is involved in the pat hogenesis of dia- betic nephropathy[J]. Diabetes, 2005,54 ( 1 ) : 243- 501.
  • 6Wang JJ, Zhang SX, Mott R, et al. Anti-inflammatory effects of pigment epithelium-derived factor in diabetic nephropathy[J]. A- merican Journal of Physiology,2008,294(5): 1 165- 1 173.
  • 7Ide Y, Matsui T, Ishibashi Y, et al. Pigment epithelium-derived factor inhibits advanced glycation end product-elicited mesangial cell damage by blocking NF-kappaB activation [J]. Microvasc Res,2010,80(2) :227-232.
  • 8Elahy M, Baindur Hudson, Cruzat VF, et al. Mechanisms of PEDF-mediated protection against reactive oxygen species dam- age in diabetie retinopathy and neuropathy[J]. Am J Physiol Renal Physiol,2013,305(3) :891-900.
  • 9Chen H, Zheng Z, Li R, et al. Urinary pigment epithelium-de- rived factor as a marker of diabetic nephropatby[J]. Am J Nephrol,2010,32(1) :47-56.
  • 10Terawaki H, Yamagishi S,Funakoshi Y, et al. Pigment epitheli- um-derived factor as a new predictor of mortality among chronic kidney disease patients treated with hemodialysis[J]. Clin Endocrinol Metab,2013,17(6) :625-630.

二级参考文献14

  • 1李春霖,龚燕平,田慧.糖适平与胰岛素对老年男性Ⅱ型糖尿病早期肾病患者降糖疗效以及肾功能影响的对比观察[J].中国药物应用与监测,2005,2(3):6-8. 被引量:6
  • 2王鸿利.实验诊断学[M].北京:人民卫生出版社,2004.240,241.
  • 3Rickela MR, Naji A, Teff KL. Insulin sensitivity glucose effec- tiveness and free fatty acid dynamics after human islet transplan- tation for type I diabetes[J]. J Clin Endocrinol Metab, 2006,91 (6):2 138-2 144.
  • 4Paolisso G, Tataranni PA, Foley J E,et al. A high concentration of fasting plasma non esterified fatty acids is a risk factor for the de- velopment of NIDDM[J]. Diabetologia,1995,38(10):l 213-1 217.
  • 5World Health Organization. Department of noncommunicable dis- ease surveillance,definition, diagnosis and classification of diabeI tes mellitus and its complications report of a WHO consultation. Part I Diagnosis and classification of diabetes mellitus[M]. Ge- neva: WH(), 1999:4-7.
  • 6Mogensen CE, Schmitz A, Christensen CK. Comparative renal pathophysiology relevant to IDDM and N1DDM patients[J]. Diabetes Metab Rrv, 1988,4(5);453-483.
  • 7Weinert LS, Camargo EG, Soares AA, et al. Glomerular filtra- tion rate estimation performance of serum cystatin C based pre- diction equations[J]. Clin hem Lab Med, 2011,49 ( 1 1 ) ; 1 761 -1 771.
  • 8Massy ZA, Ceballos I, Chadefauvekemens B, et al. Homocys- tine oxidative stress and endothelium function in uremic patients [J]. Kidney Iat, 2001,78 (Suppl) : 243- 245.
  • 9Bostom A,Brosnan JT, Hall B, et al. Net uptake of plasma ho mocysteine by the rat kidney in vitro[J]. Atheerosclerosis, 1995,116(1) :59-62.
  • 10毕慧欣,谌南岚,袁新科,凌光辉,袁曙光,黄谷香,刘瑞洪.2型糖尿病合并非糖尿病肾病的临床及病理分析[J].中国中西医结合肾病杂志,2010,11(12):1069-1071. 被引量:21

共引文献5

同被引文献47

二级引证文献71

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部